PUT - SPRINTER OPEN END - BRISTOL-MYERS SQUIBB | Market Closed - Börse Stuttgart 15:43:04 2024-05-31 EDT | ||
| 4.47 EUR | -1.32% |
|
| Current month | +5.92% | ||
| 1 month | +5.92% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 4.47 | -1.32% |
| 24-05-30 | 4.53 | -.--% |
| 24-05-29 | 4.53 | +0.67% |
| 24-05-28 | 4.5 | +2.27% |
| 24-05-27 | 4.4 | -0.68% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 03:43 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VV39WV |
| ISIN | DE000VV39WV5 |
| Date issued | 2022-06-28 |
| Strike | 89.32 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.2 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.56 € |
|---|---|
| Lowest since issue | 0.91 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.09
USD
Average target price
53.19
USD
Spread / Average Target
+29.46%
- Stock Market
- Certificates
- Certificat
